{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:20:06Z","timestamp":1781194806344,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Klinikum der Universit\u00e4t M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Gerontol Geriat"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The consensus definition of sarcopenia enables a\u00a0clear diagnostic algorithm. The syndrome can now also be coded in Germany (International Classification of Diseases 10, ICD-10 GM 62.50). Compared to the estimated prevalence it is still significantly underdiagnosed. Current treatment options include resistance training and a\u00a0protein-rich diet, while pharmacological options are still missing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The Munich Sarcopenia Registry (MUSAR) aims to raise awareness of the syndrome and affected individuals. Additionally, it seeks to gain insights into risk factors, causes and treatment approaches. This publication conducts an initial analysis of 90\u00a0patient datasets with varying degrees of sarcopenia and examines the cohort for key geriatric parameters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Material and methods<\/jats:title>\n            <jats:p>Since 2018 patients from the geriatric clinic of the Ludwig Maximilians University Munich have been able to contribute their data to the registry. Sociodemographic, anthropometric, functional, and laboratory data are collected in a\u00a0web-based registry.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Compared to patients without sarcopenia, patients with sarcopenia are significantly older, have more comorbidities and show poorer functional performance as well as reduced quality of life.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>The results highlight the urgent need for further research and the development of new forms of treatment to improve the quality of life and independence of these patients. Challenges such as difficult recruitment complicate this endeavor. The MUSAR aims to minimize these issues and provides a\u00a0valuable basis for generating extensive data through the systematic collection of patient data during hospital stays.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00391-025-02428-2","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T19:44:20Z","timestamp":1744141460000},"page":"197-202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The MUnich SArcopenia Registry (MUSAR)","Das MUenchner SArkopenie Register (MUSAR)"],"prefix":"10.1007","volume":"58","author":[{"given":"Olivia","family":"Tausendfreund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Reif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Rippl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Schluessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Schmidmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Drey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"2428_CR1","volume-title":"Decade of healthy ageing: baseline report","author":"World Health Organization&nbsp;","year":"2020","unstructured":"World Health Organization (2020) Decade of healthy ageing: baseline report. Geneva. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"2428_CR2","doi-asserted-by":"publisher","first-page":"155533","DOI":"10.1016\/j.metabol.2023.155533","volume":"144","author":"S Yuan","year":"2023","unstructured":"Yuan\u00a0S, Larsson\u00a0SC (2023) Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism 144:155533","journal-title":"Metabolism"},{"issue":"5","key":"2428_CR3","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1111\/jgs.18227","volume":"71","author":"JM Guralnik","year":"2023","unstructured":"Guralnik\u00a0JM et\u00a0al (2023) Limited physician knowledge of sarcopenia: a\u00a0survey. J\u00a0Am Geriatr Soc 71(5):1595\u20131602","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"2428_CR4","doi-asserted-by":"publisher","first-page":"e0185837","DOI":"10.1371\/journal.pone.0185837","volume":"12","author":"EM Reijnierse","year":"2017","unstructured":"Reijnierse\u00a0EM et\u00a0al (2017) Lack of knowledge and availability of diagnostic equipment could hinder the diagnosis of sarcopenia and its management. PLoS ONE 12(10):e185837","journal-title":"PLoS ONE"},{"issue":"3","key":"2428_CR5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"L-K Chen","year":"2020","unstructured":"Chen\u00a0L\u2011K et\u00a0al (2020) Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J\u00a0Am Med Dir Assoc 21(3):300\u2013307.e2","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"2428_CR6","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/gerona\/glu012","volume":"69","author":"RR McLean","year":"2014","unstructured":"McLean\u00a0RR et\u00a0al (2014) Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the national institutes of health (FNIH) sarcopenia project. J\u00a0Gerontol A Biol Sci Med Sci 69(5):576\u2013583","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"2428_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft\u00a0AJ et\u00a0al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16\u201331","journal-title":"Age Ageing"},{"issue":"6","key":"2428_CR8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jamda.2019.12.011","volume":"21","author":"M Drey","year":"2020","unstructured":"Drey\u00a0M et\u00a0al (2020) German version of SARC-F:\u00a0translation, adaption, and validation. J\u00a0Am Med Dir Assoc 21(6):747\u2013751.e1","journal-title":"J Am Med Dir Assoc"},{"issue":"8","key":"2428_CR9","first-page":"A-352","volume":"115","author":"A Hillienhof","year":"2018","unstructured":"Hillienhof\u00a0A (2018) Sarkopenie: neuer diagnoseschl\u00fcssel f\u00fcr altersbedingten muskelabbau. Dtsch Arztebl Int 115(8):A-352\u2013A-352","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"2428_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.14283\/jfa.2017.30","volume":"7","author":"B Vellas","year":"2018","unstructured":"Vellas\u00a0B et\u00a0al (2018) Implications of ICD-10 for sarcopenia clinical practice and clinical trials: report by the international conference on frailty and sarcopenia research task force. J\u00a0Frailty Aging 7(1):2\u20139","journal-title":"J Frailty Aging"},{"issue":"3","key":"2428_CR11","first-page":"114","volume":"4","author":"M Cesari","year":"2015","unstructured":"Cesari\u00a0M et\u00a0al (2015) Pharmacological interventions in frailty and sarcopenia: report by the international conference on frailty and sarcopenia research task force. J\u00a0Frailty Aging 4(3):114\u2013120","journal-title":"J Frailty Aging"},{"issue":"1","key":"2428_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12874-021-01252-7","volume":"21","author":"CO Schmidt","year":"2021","unstructured":"Schmidt\u00a0CO et\u00a0al (2021) Facilitating harmonized data quality assessments. A\u00a0data quality framework for observational health research data collections with software implementations in R. BMC Med Res Methodol 21(1):63","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2428_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12891-019-2510-7","volume":"20","author":"R Lewis","year":"2019","unstructured":"Lewis\u00a0R et\u00a0al (2019) Strategies for optimizing musculoskeletal health in the 21(st) century. BMC Musculoskelet Disord 20(1):164","journal-title":"BMC Musculoskelet Disord"},{"issue":"8","key":"2428_CR14","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s12603-009-0200-0","volume":"13","author":"G Abellan van Kan","year":"2009","unstructured":"Abellan van Kan\u00a0G et\u00a0al (2009) Carla task force on sarcopenia: propositions for clinical trials. J\u00a0Nutr Health Aging 13(8):700\u2013707","journal-title":"J Nutr Health Aging"},{"issue":"10","key":"2428_CR15","first-page":"433","volume":"115","author":"K Gie\u00dfelmann","year":"2018","unstructured":"Gie\u00dfelmann\u00a0K (2018) Studienevidenz: alte menschen unterrepr\u00e4sentiert. Dtsch Arztebl Int 115(10):433\u2013434","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"2428_CR16","doi-asserted-by":"publisher","first-page":"ii101","DOI":"10.1136\/ard.2004.030825","volume":"64 Suppl 2","author":"DD Gladman","year":"2005","unstructured":"Gladman\u00a0DD, Menter\u00a0A (2005) Introduction\/overview on clinical registries. Ann Rheum Dis 64 Suppl 2(2):ii101\u2013ii102","journal-title":"Ann Rheum Dis"},{"key":"2428_CR17","volume-title":"Registries for Evaluating Patient Outcomes: A\u00a0User\u2019s Guide","author":"Agency for Healthcare Research and Quality","year":"2014","unstructured":"Agency for Healthcare Research and Quality (2014) AHRQ Methods for Effective Health Care. In: Gliklich\u00a0RE, Dreyer\u00a0NA, Leavy\u00a0MB (eds) Registries for Evaluating Patient Outcomes: A\u00a0User\u2019s Guide. Agency for Healthcare Research and Quality, Rockville (MD), USA"},{"issue":"1","key":"2428_CR18","first-page":"7","volume":"92","author":"B Pop","year":"2019","unstructured":"Pop\u00a0B et\u00a0al (2019) The role of medical registries, potential applications and limitations. Med Pharm Rep 92(1):7\u201314","journal-title":"Med Pharm Rep"},{"issue":"1","key":"2428_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s40520-016-0715-2","volume":"29","author":"F Landi","year":"2017","unstructured":"Landi\u00a0F et\u00a0al (2017) The \u201csarcopenia and physical fRailty IN older people: multi-componenT treatment strategies\u201d (SPRINTT) randomized controlled trial: design and methods. Aging Clin Exp Res 29(1):89\u2013100","journal-title":"Aging Clin Exp Res"},{"issue":"5","key":"2428_CR20","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/ageing\/afab084","volume":"50","author":"MD Witham","year":"2021","unstructured":"Witham\u00a0MD et\u00a0al (2021) Developing a\u00a0UK sarcopenia registry: recruitment and baseline characteristics of the sarcNet pilot. Age Ageing 50(5):1762\u20131769","journal-title":"Age Ageing"},{"issue":"16","key":"2428_CR21","first-page":"783","volume":"114","author":"J Windeler","year":"2017","unstructured":"Windeler\u00a0J et\u00a0al (2017) Patientenregister f\u00fcr die nutzenbewertung: kein ersatz f\u00fcr randomisierte studien. Dtsch Arztebl Int 114(16):783","journal-title":"Dtsch Arztebl Int"},{"key":"2428_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jclinepi.2016.08.003","volume":"80","author":"G Li","year":"2016","unstructured":"Li\u00a0G et\u00a0al (2016) Registry-based randomized controlled trials-what are the advantages, challenges, and areas for future research? J\u00a0Clin Epidemiol 80:16\u201324","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"2428_CR23","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s41999-018-0108-5","volume":"9","author":"D Sanchez-Rodriguez","year":"2018","unstructured":"Sanchez-Rodriguez\u00a0D, Bruy\u00e8re\u00a0O (2018) The international registry of patients with sarcopenia: applying research in sarcopenia to clinical practice. Eur Geriatr Med 9(6):735\u2013738","journal-title":"Eur Geriatr Med"},{"issue":"8","key":"2428_CR24","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s41431-019-0386-5","volume":"27","author":"C Staunton","year":"2019","unstructured":"Staunton\u00a0C, Slokenberga\u00a0S, Mascalzoni\u00a0D (2019) The GDPR and the research exemption: considerations on the necessary safeguards for research biobanks. Eur J Hum Genet 27(8):1159\u20131167","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"2428_CR25","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/fampra\/cmv052","volume":"32","author":"M Moharra","year":"2015","unstructured":"Moharra\u00a0M et\u00a0al (2015) Implementation of a\u00a0cross-border health service: physician and pharmacists\u2019 opinions from the epSOS project. Fam Pract 32(5):564\u2013567","journal-title":"Fam Pract"},{"key":"2428_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/eurpub\/ckv169.006","volume":"25","author":"M Zaletel","year":"2015","unstructured":"Zaletel\u00a0M et\u00a0al (2015) Methodological guidelines and recommendations for efficient and rationale governance of patient registries: metka zalatel. Eur J Public Health 25:3","journal-title":"Eur J Public Health"},{"issue":"5","key":"2428_CR27","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s00103-004-0828-1","volume":"47","author":"K Wegscheider","year":"2004","unstructured":"Wegscheider\u00a0K (2004) Medizinische register. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47(5):416\u2013421","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"}],"container-title":["Zeitschrift f\u00fcr Gerontologie und Geriatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-025-02428-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00391-025-02428-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-025-02428-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T14:44:42Z","timestamp":1746197082000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00391-025-02428-2"}},"subtitle":["Paving the way for increased visibility, more frequent diagnoses and innovative new treatment","Wegbereiter f\u00fcr mehr Sichtbarkeit, h\u00e4ufigere Diagnosestellung und innovative neue Therapien"],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["2428"],"URL":"https:\/\/doi.org\/10.1007\/s00391-025-02428-2","relation":{},"ISSN":["0948-6704","1435-1269"],"issn-type":[{"value":"0948-6704","type":"print"},{"value":"1435-1269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"O.\u00a0Tausendfreund, U.\u00a0Ferrari, C.\u00a0Held, S.\u00a0Martini, K.\u00a0Mueller, H.\u00a0Reif, M.\u00a0Rippl, S.\u00a0Schluessel, R.\u00a0Schmidmaier and M.\u00a0Drey declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of the Medical Faculty of Ludwig Maximilians University (LMU) Munich, Germany (vote no 17-874). Trial registration: German Clinical Trials Register, DRKS-ID: DRKS00020504, retrospectively registered 12 March 2021. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}